FDA clears latest version of Siemens Acuson SC2000 ultrasound

The latest version of Siemens Healthcare’s Acuson SC2000 volume imaging ultrasound system has received 510(k) clearance from the FDA and is now commercially available in the U.S.

Release 2.0 of the Acuson SC2000 echocardiography system offers a number of new applications, including the quantification of the 3D proximal isovelocity surface area (PISA) to assess the severity of valvular disease and volumetric color Doppler. The system also supports volumetric intracardiac echocardiography, enabling integration of the Acuson AcuNav ultrasound catheters, according to Siemens.

Acuson SC2000 also enables the production of real-time, full-volume cardiac images in one heart cycle.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.